$SMG
SCOTTS MIRACLE-GRO CO

2011 Q2 Form 10-Q Financial Statement

#000154638012000005 Filed on May 08, 2012

View on sec.gov

Income Statement

Concept 2011 Q2
Revenue $1.123B
YoY Change 6.87%
Cost Of Revenue $665.6M
YoY Change 4.7%
Gross Profit $463.8M
YoY Change 11.76%
Gross Profit Margin 41.3%
Selling, General & Admin $216.2M
YoY Change 0.42%
% of Gross Profit 46.61%
Research & Development $13.40M
YoY Change
% of Gross Profit 2.89%
Depreciation & Amortization $15.30M
YoY Change 4.08%
% of Gross Profit 3.3%
Operating Expenses $216.2M
YoY Change -0.96%
Operating Profit $245.6M
YoY Change 24.86%
Interest Expense $13.80M
YoY Change -197.87%
% of Operating Profit 5.62%
Other Income/Expense, Net
YoY Change
Pretax Income $231.8M
YoY Change 26.94%
Income Tax $83.20M
% Of Pretax Income 35.89%
Net Earnings $177.6M
YoY Change 49.87%
Net Earnings / Revenue 15.82%
Basic Earnings Per Share $2.70
Diluted Earnings Per Share $2.63
COMMON SHARES
Basic Shares Outstanding 65.80M shares
Diluted Shares Outstanding 67.60M shares

Balance Sheet

Concept 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $128.7M
YoY Change 236.03%
Cash & Equivalents $128.7M
Short-Term Investments
Other Short-Term Assets $164.5M
YoY Change -62.08%
Inventory $556.1M
Prepaid Expenses
Receivables $1.142B
Other Receivables $0.00
Total Short-Term Assets $1.992B
YoY Change -0.44%
LONG-TERM ASSETS
Property, Plant & Equipment $396.1M
YoY Change 9.21%
Goodwill $305.8M
YoY Change
Intangibles $344.7M
YoY Change
Long-Term Investments $0.00
YoY Change
Other Assets $36.40M
YoY Change 24.66%
Total Long-Term Assets $1.083B
YoY Change 3.03%
TOTAL ASSETS
Total Short-Term Assets $1.992B
Total Long-Term Assets $1.083B
Total Assets $3.075B
YoY Change 0.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $365.9M
YoY Change 21.24%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $764.6M
YoY Change 212.98%
Total Short-Term Liabilities $1.639B
YoY Change 61.32%
LONG-TERM LIABILITIES
Long-Term Debt $416.0M
YoY Change -64.01%
Other Long-Term Liabilities $231.0M
YoY Change 12.19%
Total Long-Term Liabilities $647.0M
YoY Change -52.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.639B
Total Long-Term Liabilities $647.0M
Total Liabilities $2.286B
YoY Change -3.86%
SHAREHOLDERS EQUITY
Retained Earnings $573.3M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $139.0M
YoY Change
Treasury Stock Shares 2.600M shares
Shareholders Equity $788.6M
YoY Change
Total Liabilities & Shareholders Equity $3.075B
YoY Change 0.75%

Cashflow Statement

Concept 2011 Q2
OPERATING ACTIVITIES
Net Income $177.6M
YoY Change 49.87%
Depreciation, Depletion And Amortization $15.30M
YoY Change 4.08%
Cash From Operating Activities -$434.3M
YoY Change -0.09%
INVESTING ACTIVITIES
Capital Expenditures -$16.40M
YoY Change -11.35%
Acquisitions
YoY Change
Other Investing Activities $250.0M
YoY Change
Cash From Investing Activities $233.6M
YoY Change -1362.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 251.2M
YoY Change -43.23%
NET CHANGE
Cash From Operating Activities -434.3M
Cash From Investing Activities 233.6M
Cash From Financing Activities 251.2M
Net Change In Cash 50.50M
YoY Change -571.96%
FREE CASH FLOW
Cash From Operating Activities -$434.3M
Capital Expenditures -$16.40M
Free Cash Flow -$417.9M
YoY Change 0.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
150000000 USD
CY2011Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
365900000 USD
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
346100000 USD
CY2011Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
323500000 USD
CY2011Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1142300000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
899000000 USD
CY2011Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
485100000 USD
CY2012Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
534400000 USD
CY2011Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
510500000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-78500000 USD
CY2011Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-71400000 USD
CY2011Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-78000000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
4900000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
5400000 USD
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9800000 USD
CY2011Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7900000 USD
CY2011Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12900000 USD
CY2011Q2 us-gaap Assets
Assets
3074600000 USD
CY2012Q1 us-gaap Assets
Assets
3069700000 USD
CY2011Q3 us-gaap Assets
Assets
2052200000 USD
CY2011Q2 us-gaap Assets Current
AssetsCurrent
1991600000 USD
CY2011Q3 us-gaap Assets Current
AssetsCurrent
992500000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
2026600000 USD
CY2010Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88100000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
122400000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
130900000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
128700000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8500000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
40600000 USD
CY2011Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.60
CY2011Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.25
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
11.50
smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
200000 USD
CY2011Q2 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
425700000 USD
CY2012Q1 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
412500000 USD
CY2011Q3 us-gaap Common Stock Including Additional Paid In Capital
CommonStockIncludingAdditionalPaidInCapital
427100000 USD
CY2011Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
60800000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61100000 shares
CY2011Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65700000 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61100000 shares
CY2011Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60800000 shares
CY2011Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65700000 shares
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
128900000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
115400000 USD
CY2011Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
172100000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52800000 USD
us-gaap Contract Revenue Cost
ContractRevenueCost
10000000 USD
CY2011Q2 us-gaap Contract Revenue Cost
ContractRevenueCost
5000000 USD
us-gaap Contract Revenue Cost
ContractRevenueCost
10000000 USD
CY2012Q1 us-gaap Contract Revenue Cost
ContractRevenueCost
5000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
896900000 USD
CY2012Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
710500000 USD
CY2011Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
665600000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
845900000 USD
us-gaap Depreciation
Depreciation
25400000 USD
us-gaap Depreciation
Depreciation
24600000 USD
CY2011Q3 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-26100000 USD
CY2011Q2 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-10800000 USD
CY2012Q1 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-23600000 USD
CY2012Q1 us-gaap Discontinued Operation Amount Of Continuing Cash Flows After Disposal
DiscontinuedOperationAmountOfContinuingCashFlowsAfterDisposal
50000000 USD
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.86
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.63
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.05
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1400000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1600000 USD
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.371
CY2011Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.359
CY2012Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
18700000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition
2.1 Year
CY2011Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2500000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3400000 USD
CY2012Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2800000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4200000 USD
CY2011Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
0 USD
CY2012Q1 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
0 USD
CY2011Q2 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
0 USD
CY2011Q3 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2012Q1 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2011Q2 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4800000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4400000 USD
us-gaap Fees And Commissions Other
FeesAndCommissionsOther
33400000 USD
CY2011Q2 us-gaap Fees And Commissions Other
FeesAndCommissionsOther
32900000 USD
us-gaap Fees And Commissions Other
FeesAndCommissionsOther
32900000 USD
CY2012Q1 us-gaap Fees And Commissions Other
FeesAndCommissionsOther
33400000 USD
CY2012Q1 us-gaap Goodwill
Goodwill
309100000 USD
CY2011Q2 us-gaap Goodwill
Goodwill
305800000 USD
CY2011Q3 us-gaap Goodwill
Goodwill
309100000 USD
us-gaap Gross Profit
GrossProfit
487600000 USD
CY2011Q2 us-gaap Gross Profit
GrossProfit
462700000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
462800000 USD
us-gaap Gross Profit
GrossProfit
511800000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
148600000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
53300000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
81900000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
127200000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
200300000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
231800000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
127800000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
84800000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.88
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.24
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.09
CY2011Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.26
CY2011Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.20
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.21
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.05
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.86
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0 USD
CY2011Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
29000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
27800000 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
CY2011Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
29000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
27800000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.42
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2011Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.44
CY2011Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.43
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.41
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2012Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2011Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
45900000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
83200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31500000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73100000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13300000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4200000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
223400000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
201200000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
807400000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
801700000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
202100000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
213300000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
132600000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
141400000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-5000000 USD
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3400000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
25500000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34400000 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-100000 USD
us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-11100000 USD
CY2011Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
344700000 USD
CY2012Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
311800000 USD
CY2011Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
319600000 USD
us-gaap Interest Expense
InterestExpense
23300000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
17900000 USD
CY2011Q2 us-gaap Interest Expense
InterestExpense
13800000 USD
us-gaap Interest Expense
InterestExpense
33200000 USD
us-gaap Interest Paid Net
InterestPaidNet
30700000 USD
us-gaap Interest Paid Net
InterestPaidNet
18600000 USD
CY2011Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
130700000 USD
CY2012Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
397100000 USD
CY2011Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
363400000 USD
CY2011Q3 us-gaap Inventory Net
InventoryNet
387000000 USD
CY2012Q1 us-gaap Inventory Net
InventoryNet
601600000 USD
CY2011Q2 us-gaap Inventory Net
InventoryNet
556100000 USD
CY2011Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
222000000 USD
CY2011Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
159700000 USD
CY2012Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
161000000 USD
CY2011Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31200000 USD
CY2011Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
31400000 USD
CY2012Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
26500000 USD
CY2011Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
34300000 USD
CY2012Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
43500000 USD
CY2011Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
33000000 USD
CY2012Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
25500000 USD
CY2011Q3 us-gaap Liabilities
Liabilities
1492400000 USD
CY2012Q1 us-gaap Liabilities
Liabilities
2480000000 USD
CY2011Q2 us-gaap Liabilities
Liabilities
2286000000 USD
CY2011Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2052200000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3069700000 USD
CY2011Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3074600000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1012400000 USD
CY2011Q3 us-gaap Liabilities Current
LiabilitiesCurrent
468600000 USD
CY2011Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1639000000 USD
CY2012Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
837400000 USD
CY2011Q2 us-gaap Long Term Debt
LongTermDebt
1180600000 USD
CY2012Q1 us-gaap Long Term Debt
LongTermDebt
1469000000 USD
CY2011Q3 us-gaap Long Term Debt
LongTermDebt
795000000 USD
CY2011Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
764600000 USD
CY2011Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3200000 USD
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
227800000 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1241200000 USD
CY2011Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
791800000 USD
CY2011Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
416000000 USD
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONTINGENCIES</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management regularly evaluates the Company&#8217;s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers&#8217; compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance reserves are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, its assessment of contingencies is reasonable and related reserves, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company&#8217;s financial condition, results of operations or cash flows. The following are the more significant of the Company&#8217;s identified contingencies:</font></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">FIFRA Compliance and the Corresponding Governmental Investigations</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For a description of the Company&#8217;s ongoing FIFRA compliance efforts and the corresponding governmental investigations and related settlement discussions, see &#8220;NOTE&#160;3. PRODUCT REGISTRATION AND RECALL MATTERS.&#8221;</font></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Other Regulatory Matters</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4.1 million</font><font style="font-family:inherit;font-size:10pt;"> was accrued in the &#8220;Other liabilities&#8221; line in the Condensed Consolidated Balance Sheet for non-FIFRA compliance-related environmental actions, the majority of which is for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.</font></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company&#8217;s historic use of vermiculite in certain of its products. The complaints in these cases are not specific about the plaintiffs&#8217; contacts with the Company or its products. The Company in each case is one of numerous defendants and none of the claims seek damages from the Company alone. The Company believes that the claims against it are without merit and is vigorously defending against them. It is not currently possible to reasonably estimate a probable loss, if any, associated with these cases and, accordingly, no reserves have been recorded in the Company&#8217;s condensed consolidated financial statements. The Company is reviewing agreements and policies that may provide insurance coverage or indemnity as to these claims and is pursuing coverage under some of these agreements and policies, although there can be no assurance of the results of these efforts. There can be no assurance that these cases, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company&#8217;s financial condition, results of operations or cash flows.</font></div></div>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
437500000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
635700000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25200000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
205500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-620400000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-604000000 USD
us-gaap Net Income Loss
NetIncomeLoss
109700000 USD
us-gaap Net Income Loss
NetIncomeLoss
53300000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
127200000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
177600000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
151100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
118000000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
245600000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
218200000 USD
CY2012Q1 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
200000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
400000 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
400000 USD
CY2011Q2 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
200000 USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34400000 USD
CY2011Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36300000 USD
CY2011Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36400000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
7100000 USD
CY2012Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
200000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
2100000 USD
CY2011Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
5700000 USD
CY2012Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease
2900000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease
2300000 USD
us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease
8100000 USD
CY2011Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease
500000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-4900000 USD
CY2011Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-11700000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-9500000 USD
CY2012Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
-1400000 USD
CY2011Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
508500000 USD
CY2011Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
315400000 USD
CY2012Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
438500000 USD
CY2011Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
231000000 USD
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
226400000 USD
CY2011Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
232000000 USD
CY2012Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2011Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8800000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
4700000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
800000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2200000 USD
CY2012Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1300000 USD
CY2011Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
300000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
93700000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17500000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
37200000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
33300000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4100000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25700000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44500000 USD
CY2011Q3 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
0 USD
CY2012Q1 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
234200000 USD
CY2011Q2 us-gaap Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value
PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue
0 USD
CY2011Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
164500000 USD
CY2012Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
169400000 USD
CY2011Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
151100000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
249800000 USD
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
200000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
1705600000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
993700000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12400000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21800000 USD
CY2011Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
396100000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
387800000 USD
CY2011Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
394700000 USD
CY2011Q2 us-gaap Reimbursement Revenue
ReimbursementRevenue
19000000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
41200000 USD
CY2012Q1 us-gaap Reimbursement Revenue
ReimbursementRevenue
23300000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
34200000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1032400000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
651300000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
5300000 USD
CY2011Q3 us-gaap Restructuring Reserve
RestructuringReserve
29600000 USD
CY2012Q1 us-gaap Restructuring Reserve
RestructuringReserve
20800000 USD
CY2012Q1 us-gaap Restructuring Reserve Period Expense
RestructuringReservePeriodExpense
7200000 USD
CY2011Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 USD
CY2012Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
5600000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
8200000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
620100000 USD
CY2011Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
573300000 USD
CY2011Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
599200000 USD
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1173500000 USD
CY2011Q2 us-gaap Sales Revenue Net
SalesRevenueNet
1129600000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1359800000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1384700000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
360000000 USD
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
216200000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
359400000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
237000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10800000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8900000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7300000 USD
CY2011Q2 us-gaap Share Based Compensation
ShareBasedCompensation
6500000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
5.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.332
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
100000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10200000 USD
CY2012Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2600000 shares
CY2012Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
3800000 shares
CY2012Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
31.00
CY2012Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm1
3.78
CY2012Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
35.95
CY2012Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1
5.32
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
13500000 USD
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
17000000 USD
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
400000 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
7900000 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
17500000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
401200000 USD
CY2011Q2 us-gaap Stockholders Equity
StockholdersEquity
788600000 USD
CY2011Q3 us-gaap Stockholders Equity
StockholdersEquity
559800000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
589700000 USD
CY2011Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
7500000 shares
CY2011Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2600000 shares
CY2012Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7100000 shares
CY2012Q1 us-gaap Treasury Stock Value
TreasuryStockValue
364400000 USD
CY2011Q2 us-gaap Treasury Stock Value
TreasuryStockValue
139000000 USD
CY2011Q3 us-gaap Treasury Stock Value
TreasuryStockValue
388500000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and related disclosures. Although these estimates are based on management&#8217;s best knowledge of current events and actions the Company may undertake in the future, actual results ultimately may differ from the estimates.</font></div></div>
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67700000 shares
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61700000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
66100000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60900000 shares
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60600000 shares
smg Aggregate Stock Repurchase Program Authorized Repurchase Amount
AggregateStockRepurchaseProgramAuthorizedRepurchaseAmount
700000000 USD
CY2011Q2 smg Commission Income Expense Net
CommissionIncomeExpenseNet
27700000 USD
CY2012Q1 smg Commission Income Expense Net
CommissionIncomeExpenseNet
28200000 USD
smg Commission Income Expense Net
CommissionIncomeExpenseNet
22500000 USD
smg Commission Income Expense Net
CommissionIncomeExpenseNet
23000000 USD
CY2012Q1 smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
200000 USD
CY2011Q2 smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
1300000 USD
smg Cost Of Goods Sold Product Registration And Recall
CostOfGoodsSoldProductRegistrationAndRecall
2100000 USD
CY2012Q1 smg Discontinued Operation Amount Of Long Term Purchase Commitment
DiscontinuedOperationAmountOfLongTermPurchaseCommitment
15000000 USD
smg Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
smg Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
90600000 USD
smg Gain Loss On Sale Of Long Lived Assets
GainLossOnSaleOfLongLivedAssets
100000 USD
smg Gain Loss On Sale Of Long Lived Assets
GainLossOnSaleOfLongLivedAssets
100000 USD
smg Grant Of Share Based Compensation Awards
GrantOfShareBasedCompensationAwards
708243000000 shares
smg Grant Of Share Based Compensation Awards
GrantOfShareBasedCompensationAwards
574482000000 shares
CY2011Q3 smg Intercompany Assets
IntercompanyAssets
0 USD
CY2012Q1 smg Intercompany Assets
IntercompanyAssets
0 USD
CY2011Q2 smg Intercompany Assets
IntercompanyAssets
0 USD
CY2011Q3 smg Intercompany Liabilities
IntercompanyLiabilities
0 USD
CY2012Q1 smg Intercompany Liabilities
IntercompanyLiabilities
0 USD
CY2011Q2 smg Intercompany Liabilities
IntercompanyLiabilities
0 USD
CY2012Q1 smg Interest Coverage Ratio
InterestCoverageRatio
5.80
CY2012Q1 smg Leverage Ratio
LeverageRatio
2.51
CY2012Q1 smg Line Of Credit Facility Potential Loss Borrowing Capacity
LineOfCreditFacilityPotentialLossBorrowingCapacity
45000000 USD
CY2012Q1 smg Loss Contingency Potential Claims Number
LossContingencyPotentialClaimsNumber
11 LegalMatter
CY2012Q1 smg Minimum Unutilized Proceed Before Making Note Repurchase Offer
MinimumUnutilizedProceedBeforeMakingNoteRepurchaseOffer
50000000 USD
CY2012Q1 smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
51500000 USD
smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
56700000 USD
CY2011Q2 smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
46700000 USD
smg Net Sales With Agency Agreement
NetSalesWithAgencyAgreement
64200000 USD
smg Payments For Proceeds From Intercompany Advances From Financing Activities
PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities
0 USD
smg Payments For Proceeds From Intercompany Advances From Financing Activities
PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities
0 USD
smg Payments For Restructuring And Other
PaymentsForRestructuringAndOther
11100000 USD
CY2012Q1 smg Proceed Utilization Period
ProceedUtilizationPeriod
P360D
smg Proceeds From Sale Of Long Lived Assets
ProceedsFromSaleOfLongLivedAssets
200000 USD
smg Proceeds From Sale Of Long Lived Assets
ProceedsFromSaleOfLongLivedAssets
500000 USD
smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
3600000 USD
smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
2100000 USD
CY2011Q2 smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
1200000 USD
CY2012Q1 smg Product Registration And Recall Matters
ProductRegistrationAndRecallMatters
3300000 USD
CY2012Q1 smg Regulatory Matters Other Liabilities
RegulatoryMattersOtherLiabilities
4100000 USD
smg Restructuring Reserve Period Expense And Other Related Charges
RestructuringReservePeriodExpenseAndOtherRelatedCharges
2300000 USD
smg Tax Benefit Realized From Tax Deduction Associated With Exercise Of Stock Option
TaxBenefitRealizedFromTaxDeductionAssociatedWithExerciseOfStockOption
12800000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000825542
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61090597 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
SCOTTS MIRACLE-GRO CO
dei Trading Symbol
TradingSymbol
SMG

Files In Submission

Name View Source Status
0001546380-12-000005-index-headers.html Edgar Link pending
0001546380-12-000005-index.html Edgar Link pending
0001546380-12-000005.txt Edgar Link pending
0001546380-12-000005-xbrl.zip Edgar Link pending
exhibit311smg.htm Edgar Link pending
exhibit312smg.htm Edgar Link pending
exhibit32smg.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
smg-20120331.xml Edgar Link completed
smg-20120331.xsd Edgar Link pending
smg-20120331_cal.xml Edgar Link unprocessable
smg-20120331_def.xml Edgar Link unprocessable
smg-20120331_lab.xml Edgar Link unprocessable
smg-20120331_pre.xml Edgar Link unprocessable
smg-2012331x10q.htm Edgar Link pending